James Paul Scopa, Director at DICE Therapeutics, Inc. (DICE), bought 6,000 shares at $17.00 ($102K) on 2021-09-15, disclosed to the SEC on 2021-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADVM | SELL | 2021-11-17 | $218K | — | Filing → |
| ADVM | BUY | 2020-02-14 | $138K | — | Filing → |
| ADVM | BUY | 2019-05-06 | $134K | — | Filing → |